Vytorin, Zetia prescriptions rise in December

Thursday, January 22nd, 2009

Schering-Plough Corp said on Tuesday that U.S. prescriptions for the cholesterol drugs it sells with Merck & Co rose 8.7 percent in December, reclaiming most of the ground lost in November. The U.S. drugmaker, in a regulatory filing, said combined prescriptions for Vytorin and Zetia climbed back over the 2 million mark in December to about 2.15 […]

After study review, FDA says patients should not stop taking cholesterol-lowering drugs.

Friday, January 9th, 2009

 The AP (1/9, Johnson) reports, “The Food and Drug Administration (FDA) said Thursday patients should not stop taking Vytorin (ezetimibe and simvastatin) or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered Vytorin sales.” In January 2008, “initial results of a study called ENHANCE showed Vytorin was no better than […]